Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Advisors
Partners
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
EXO-Ovarian Cancer Test
Exosome Therapeutics
NeuCA15-3 Test
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
17-Oct-2025
Peter Gunzburg appointed Non-Executive Director
17-Oct-2025
Share Purchase Plan Booklet
17-Oct-2025
IIQ completes placement and lodges SPP Offer Booklet
13-Oct-2025
Investor Presentation
13-Oct-2025
INOVIQ completes $9.5m placement
9-Oct-2025
Trading Halt
1-Oct-2025
CAR-T exosome data published
26-Sep-2025
IIQ Licences worldwide OC Biomarker IP from UniQuest
22-Sep-2025
CAR-NK EVs kill Breast Cancer Cells in vitro at Peter Mac
18-Sep-2025
2025 Annual Report
Previous
1
2
3
4
Next
